Skip to main content

Clinical Pathways promote evidence-based, safe, and high-value patient care by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by a methodical review of available evidence and consensus among committee members.

Clinical Pathway:

Inclusion and Exclusion Criteria: 

  • Inclusion:  
    • Patient 1 – 18 years of age with signs and symptoms of sinusitis  
  • Exclusion:
    • Complicated sinusitis at presentation 
    • Chronis sinusitis
    •  Viral sinusitis
    •  Immunocompromised 

Committee members involved in the development:

  • Rana El Feghaly, MD, MSCI | Infectious Diseases | Committee Chair
  • Joshua Saucedo, MD | Pediatric Emergency Medicine Fellow | Committee Member
  •  Leslie Hueschen, MD | Pediatric Emergency Medicine | Committee Member
  • Marsha Dannenberg, MD | Urgent Care | Committee Member
  • Elie Khalifee, MD | Otolaryngology | Committee Member
  • Alaina Burns, PharmD, BCPPS | Infectious Diseases | Committee Member 

 EBP Committee Members:

  • Kathleen Berg, MD, FAAP | Hospitalist, Evidence Based Practice
  • Andrea Melanson, OTD, OTR/L | Evidence Based Practice 

 Publication Dates:

  • Finalized date:  10/2024
  • Next expected revision date:  2027 

Concerns with content: 

If you have any questions regarding this content or identify a broken link, please email evidencebasedpractice@cmh.edu.  

These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.